The amount of fillers approved by the United States Food
and Drug Administration (FDA) for use in facial volume
augmentation is diminutive in comparison to filler products
employed worldwide. In the near future, several new
hyaluronic acid filler products will be available to the
United States market. Already approved fillers include
Belotero Balance for fine lines, Juvéderm Voluma XC for
midfacial volume loss replacement, and Restylane Silk
for perioral lines and lip augmentation. Volbella, currently
under FDA evaluation, will be used for fine-line correction
and lip augmentation. The physiochemical properties, best
practices, clinical uses, and side effects of these fillers are
discussed. Additionally, evolving techniques such as the
use of blunt-tipped microcannulas are explained.
Semin Cutan Med Surg 33:157-163 © 2014 Frontline Medical
CommunicationsThe amount of fillers approved by the United States Food
and Drug Administration (FDA) for use in facial volume
augmentation is diminutive in comparison to filler products
employed worldwide. In the near future, several new
hyaluronic acid filler products will be available to the
United States market. Already approved fillers include
Belotero Balance for fine lines, Juvéderm Voluma XC for
midfacial volume loss replacement, and Restylane Silk
for perioral lines and lip augmentation. Volbella, currently
under FDA evaluation, will be used for fine-line correction
and lip augmentation. The physiochemical properties, best
practices, clinical uses, and side effects of these fillers are
discussed. Additionally, evolving techniques such as the
use of blunt-tipped microcannulas are explained.
Semin Cutan Med Surg 33:157-163 © 2014 Frontline Medical
Communications